Eli Lilly and Company has announced the availability of Zepbound (tirzepatide) in 2.5mg and 5mg single-dose vials for self-pay for adults with obesity. The move significantly expands the supply of ...

Eli Lilly announced on Monday it will soon make the two highest doses of its popular weight-loss drug Zepbound available for self-paying customers on its website. Starting in August, 12.5 ...

Earlier this month, the Food and Drug Administration updated its drug shortage database to indicate that all doses of tirzepatide, which Lilly sells as Zepbound for obesity and Mounjaro for ...

Starting in August, 12.5-milligram and 15-milligram single doses will be added to the company’s website, effectively making all Zepbound doses available for $499 a month or less.

The company pledged to soon make its highest marketed Zepbound strengths, the drug's 12.5 mg and 15 mg doses, available in single-dose vials for $499 a month through its LillyDirect self-pay ...

More doses of Novo Nordisk’s popular weight loss drug Wegovy are back in stock in the U.S. after years of shortages and just days after all doses of Eli Lilly’s rival injection Zepbound became ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

The price for Zepbound, the popular weight-loss drug sold by Eli Lilly, is getting reduced. A four-week supply of the 2.5 mg dose will cost $399; the 5 mg dose will cost $549. Eli Lilly says those ...

Patients are directed to start with 0.25 mg injections, and gradually increase the dose every four weeks until they reach a maintenance dose of 1.7 or 2.4 mg. Starting at that 0.25 mg dose is ...

“This is just the start,” said Waring, cautioning that she has no insider information and is just as curious as everyone else about the potential availability of higher doses of Zepbound in vials.

A spokesperson for Eli Lilly told CBS News that "all doses of Mounjaro and Zepbound" are available and have been "since early August," and that the "FDA continues to note the shortage as 'resolved.'" ...